Search research articles
Contact Us
Filters
Showing results (111-120 of 116) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 116 results.
The Journal of Clinical Investigation
|
April 4, 2023
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy
Fabian Braun, Ahmed Abed, Dominik Sellung, et al.
The EMBO Journal
|
October 28, 2025
Proteolytic profiling of human plasma reveals an immunoactive complement C3 fragment
Fatih Demir, Elina Kovalenko, Moritz Lassé, et al.
Nature Communications
|
August 14, 2023
An integrated organoid omics map extends modeling potential of kidney disease
Moritz Lassé, Jamal El Saghir, Celine C Berthier, et al.
Nature Reviews. Nephrology
|
July 28, 2025
Microbiota and kidney disease: the road ahead
Patricia P Bloom, Wendy S Garrett, Kristina L Penniston, et al.
Nature Communications
|
December 20, 2024
Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways
Naziia Kurmasheva, Aida Said, Boaz Wong, et al.
Nature Communications
|
May 15, 2024
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways
Naziia Kurmasheva, Aida Said, Boaz Wong, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 116) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 116 results.
The Journal of Clinical Investigation
|
April 4, 2023
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy
Fabian Braun, Ahmed Abed, Dominik Sellung, et al.
The EMBO Journal
|
October 28, 2025
Proteolytic profiling of human plasma reveals an immunoactive complement C3 fragment
Fatih Demir, Elina Kovalenko, Moritz Lassé, et al.
Nature Communications
|
August 14, 2023
An integrated organoid omics map extends modeling potential of kidney disease
Moritz Lassé, Jamal El Saghir, Celine C Berthier, et al.
Nature Reviews. Nephrology
|
July 28, 2025
Microbiota and kidney disease: the road ahead
Patricia P Bloom, Wendy S Garrett, Kristina L Penniston, et al.
Nature Communications
|
December 20, 2024
Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways
Naziia Kurmasheva, Aida Said, Boaz Wong, et al.
Nature Communications
|
May 15, 2024
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways
Naziia Kurmasheva, Aida Said, Boaz Wong, et al.
Page
of 12